- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02847871
Elderly Patient at Risk of Loss of Mobility, Exercise - Primary Care, Prevention, Care Pathways (PRISME-3P)
Prevention of Loss of Mobility From a Care Pathway Focused on Exercise and Nutrition in Elderly Patients Over 70 Years, in Primary Care. Cluster Randomized Controlled Trial
Loss of mobility is predictive of a loss of autonomy and is often the first sign of functional decline. Loss of mobility is also associated with poor perceived quality of life, depressive symptoms, high risk of adverse events such as falls and fractures, to an increased risk to input in institution and mortality's increase.
Consequences and frequency of loss of mobility make essential its identification, evaluation and the practice of preventive measures in primary care.
The implementation of effective interventions in primary care to prevent or delay the loss of mobility is a public health priority.
PRISME-3P program aims to develop and evaluate a dedicated care pathway, in primary care, based on a personalized multimodal intervention: screening, support combining physician, teaching exercises by a specialized Monitor in Adapted Physical Activities (MAPA) and nutritional counseling.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Pierre-Bénite, France, 69310
- Service de Médecine Gériatrique. Groupement Hospitalier Sud. Hospices Civils de Lyon.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged > 70 years
With at least 2 of the following signs:
- Difficulty in carrying a shopping bag (load about 4.5 Kg)
- Difficulty in getting up from a chair without using arms
- Difficulty in climbing 10 stairs
- Difficulty in moving, walking slow
- Difficulty in walking more than 400 meters without stop
- Running time <1 hour / week
- Fatigue at modest physical effort: shopping, housework ...
- At least two falls in the last year
- Weight loss ≥5% in 1 month or weight loss ≥10% in 6 months
- Short Physical Performance Battery score < 10
Exclusion Criteria:
- Locomotor disability not allowing implementation of the protocol according to the investigator
- Life expectancy less than 6 months
- Severe chronic progressive pathologies incompatible with the completion of the physical activity program
- Patient institutionalized in nursing homes
- Advanced Cognitive impairment (MMSE <20)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Multimodal Intervention
The multimodal intervention on mobility will consist of the implementation of a care pathway dedicated in primary care.
It will include awareness and training of general practitioners for easy identification, a care associating a dedicated geriatric consultation to rule out underlying pathology, teaching exercises by MAPA (+/- taken care in the presence of MAPA) and nutritional counseling by a dietician.
Close collaboration between general practitioners, geriatrician, MAPA and dietician will be established.
|
PRISM-3P program will consist on a visit in the geriatric centre:
|
|
No Intervention: Non interventional
Patients received treatment as part of their standard care: at the discretion of the general practitioner patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Short Physical Performance Battery (SPPB) score
Time Frame: from baseline at 6 months
|
Consists in estimating three components: 1. walking, 2. muscular strength and endurance, and 3. balance through short physical exercises (walk on a defined distance, get up from a chair, keep a position up).
A score from 1 to 3 for each of the components marks a very low feature of lower limbs.
This feature is considered low of 4 in 6, moderated by 7 in 9 and high of 10 in 12.
|
from baseline at 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evolution of the Short Physical Performance Battery (SPPB) score
Time Frame: Baseline, 3 months (for interventional arm), 6 months and 12 months
|
Consists in estimating three components: 1.walking, 2.muscular strength and endurance, and 3. balance through short physical exercises (walk on a defined distance, get up from a chair, keep a position up).
A score from 1 to 3 for each of the components marks a very low feature of lower limbs.
This feature is considered low of 4 in 6, moderated by 7 in 9 and high of 10 in 12.
|
Baseline, 3 months (for interventional arm), 6 months and 12 months
|
|
Assessment of functional disability by questionnaires
Time Frame: Baseline, 6 months and 12 months
|
Functional disability refers to limitations in performing in dependent living tasks, which are often further divided into activities of daily living (ADLs), which include basic activities of hygiene and personal care, and instrumental activities of daily living (IADLs), which include basic activities necessary to reside in the community, such as shopping, managing finances, housekeeping, and meal preparation
|
Baseline, 6 months and 12 months
|
|
Assessment of Quality of Life by questionnaire
Time Frame: baseline, 6 months and 12 months
|
The Quality of Life is assessed with the 12-Item Short Form Health Survey (SF-12).
The SF-12 is a multipurpose short form survey with 12 questions which were combined, scored, and weighted to create two scales that provide glimpses into mental and physical functioning and overall health-related-quality of life
|
baseline, 6 months and 12 months
|
|
Number of falls
Time Frame: Baseline, 6 months and 12 months
|
Data will be collected by the geriatrician from the patient's medical records
|
Baseline, 6 months and 12 months
|
|
Number of hospitalization
Time Frame: Baseline, 6 months and 12 months
|
Data will be collected by the geriatrician from the patient's medical records
|
Baseline, 6 months and 12 months
|
|
Assessment of the Physical Activity by questionnaire
Time Frame: baseline, 6 months and 12 months
|
Using the Physical Activity Scale for the Elderly (PASE) auto-questionnaire which is designed to assess the duration, frequency, exertion level, and amount of physical activity undertaken over a seven day period.
|
baseline, 6 months and 12 months
|
|
Assessment of sedentary time by questionnaire
Time Frame: baseline, 6 months and 12 months
|
Using self-report sedentary behavior questionnaire based on the Gardiner questionnaire to assess time spent in behaviors common among older adults: watching television, computer use, reading, socializing, transport and hobbies, and a summary measure (total sedentary time)
|
baseline, 6 months and 12 months
|
|
Assessment of weight loss
Time Frame: baseline, 6 months and 12 months
|
weight in kilograms
|
baseline, 6 months and 12 months
|
|
Body Mass Index (BMI)
Time Frame: baseline, 6 months and 12 months
|
calculating the BMI in kg/m^2
|
baseline, 6 months and 12 months
|
|
Assessment of nutritional status using MNA scale
Time Frame: baseline, 3 months (for interventional arm depending on the SPPB score), 6 months and 12 months
|
Using the Mini Nutritional Assessment (MNA) scale which consists of 18 point-weighted questions in four categories, i.e., anthropometry, global and dietary issues, and self-assessment.
|
baseline, 3 months (for interventional arm depending on the SPPB score), 6 months and 12 months
|
|
Rate of study participation
Time Frame: Baseline
|
Baseline
|
|
|
Monitoring of detailed physical activity performed by patients with diaries outlining the exercise sessions .
Time Frame: at the end of the multimodal intervention (3 months)
|
Patient adherence to the multimodal intervention.
Monitoring of detailed physical activity performed by patients.
Patients were also asked to complete diaries outlining the exercise sessions.
|
at the end of the multimodal intervention (3 months)
|
|
Monitoring of detailed physical activity performed by patients with MAPA assessment.
Time Frame: at the end of the multimodal intervention (3 months)
|
Patient adherence to the multimodal intervention.
Monitoring of detailed physical activity performed by patients.
Patients MAPA assessment.
|
at the end of the multimodal intervention (3 months)
|
|
Rate of compliant General practitioners (GP) associated to the study
Time Frame: at 12 months
|
at 12 months
|
|
|
Assessment of psychological factors using GDS-4 scale associated with a loss of mobility
Time Frame: baseline, 6 and 12 months
|
Using a short Geriatric Depression Scale (GDS-4).
The GDS may be used with healthy, medically ill and mild to moderately cognitively impaired older adults.
|
baseline, 6 and 12 months
|
|
Assessment of social factors associated with a loss of mobility
Time Frame: baseline
|
Using the Evaluation of Precarity and Inequalities in Health Examination Centers (EPICES) score which is related to several socioeconomic indicators (occupation, education, and employment status), to health-related behaviors (smoking and health care use), and morbidity (self-perceived health, dental health, obesity, and diabetes).
|
baseline
|
|
Assessment of comorbidities using the index of Charlson
Time Frame: baseline
|
Using the index of Charlson which included a closed list of 19 diseases, grouped into 4 subgroups different weighting.
|
baseline
|
|
Description of concomitant medications
Time Frame: baseline
|
List of active drugs and psychotropic
|
baseline
|
|
Type of diagnoses for unknown diseases following the dedicated geriatric consultation.
Time Frame: baseline
|
Description of pathologies possibly associated with a symptomatic loss of mobility.
|
baseline
|
|
Percentage of diagnoses for unknown diseases following the dedicated geriatric consultation.
Time Frame: baseline
|
Description of pathologies possibly associated with a symptomatic loss of mobility.
|
baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Marc BONNEFOY, Pr, Hospices Civils de Lyon
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL16_0132
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Elderly Patient (>70 Years)
-
Boryung Pharmaceutical Co., LtdCompletedThe Elderly (≥ 70 Years) With Essential HypertensionKorea, Republic of
-
Wecare Probiotics Co., Ltd.CompletedPeople Aged 55-70 YearsChina
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceRecruitingElderly Patient (80 Years Old or More) Admitted to Intensive CareFrance
-
ASLAN PharmaceuticalsCompletedHealthy Elderly Subjects (Age ≥55 Years)Singapore
-
Pusan National University HospitalPusan National University Yangsan HospitalUnknownElective Surgery of Gastrointestinal Tract | 100 Adults Aged Between 20 and 70 Years Old | ASA Physical Status of I or IIKorea, Republic of
-
Sichuan Academy of Medical SciencesUnknownAge:18-70 Years | Acute Severe Disease | Acute Physiology And Chronic Health Evaluation(APACHE)II>10China
-
Hasselt UniversityNot yet recruitingHealthy | Elderly | Young Adults | Older Adults (65 Years and Older)Belgium
-
University Hospital, LimogesCompletedThe Elderly of 75 Years and Living in Nursing HomesFrance
-
University Hospital, LimogesCompletedthe Elderly of 75 Years and Older Living at HomeFrance
-
Horsholm MunicipalityNot yet recruitingOutpatient Treatment | Older Adults (65 Years and Older) | Rehabilitation Frail Elderly SubjectsDenmark
Clinical Trials on PRISME-3P program
-
Bioinova, s.r.o.Department of Neurology, University Hospital Motol, Prague, Czech RepublicTerminated
-
University of CataniaCompleted
-
Bioinova, s.r.o.Department of Neurology, University Hospital Motol, Prague, Czech RepublicCompletedMotor Neuron Disease, Amyotrophic Lateral Sclerosis
-
Peking Union Medical College HospitalRecruiting
-
National Taiwan University HospitalRecruitingPancreas Adenocarcinoma | MicroRNATaiwan
-
Bioinova, s.r.o.Department of Spine Surgery, University Hospital Motol, Prague, Czech RepublilcTerminated
-
Nagasaki UniversityLondon School of Hygiene and Tropical Medicine; National Institute of Hygiene... and other collaboratorsCompleted
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...CompletedStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
National Taiwan University HospitalCompleted
-
National Yang Ming Chiao Tung UniversityCompletedBreast Cancer | Weight LossTaiwan